Beam Therapeutics, Inc. (BEAM)
23.98
-0.39
(-1.60%)
USD |
NASDAQ |
Sep 11, 16:00
24.10
+0.12
(+0.50%)
After-Hours: 16:29
Beam Therapeutics Gross Profit (TTM) : 133.79M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 133.79M |
| March 31, 2026 | 141.64M |
| December 31, 2025 | 117.45M |
| September 30, 2025 | 33.63M |
| June 30, 2025 | 38.29M |
| March 31, 2025 | 41.56M |
| December 31, 2024 | 41.59M |
| September 30, 2024 | 327.80M |
| June 30, 2024 | 328.72M |
| March 31, 2024 | 335.35M |
| December 31, 2023 | 350.58M |
| September 30, 2023 | 53.60M |
| June 30, 2023 | 54.06M |
| March 31, 2023 | 52.38M |
| December 31, 2022 | 38.34M |
| September 30, 2022 | 70.54M |
| Date | Value |
|---|---|
| June 30, 2022 | 60.36M |
| March 31, 2022 | 49.22M |
| December 31, 2021 | 46.05M |
| September 30, 2021 | -2.938M |
| June 30, 2021 | -2.938M |
| March 31, 2021 | -2.938M |
| December 31, 2020 | -2.938M |
| September 30, 2020 | -1.881M |
| June 30, 2020 | -1.881M |
| March 31, 2020 | -1.881M |
| December 31, 2019 | -2.822M |
| September 30, 2019 | -1.474M |
| June 30, 2019 | -1.538M |
| March 31, 2019 | -1.538M |
| December 31, 2018 | -0.597M |
| September 30, 2018 | -0.064M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Twist Bioscience Corp. | 224.38M |
| Prime Medicine, Inc. | -3.325M |
| Intellia Therapeutics, Inc. | 44.25M |
| Sana Biotechnology, Inc. | -10.84M |
| Sarepta Therapeutics, Inc. | 1.117B |